Xiaoning Zhu
Luzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Evaluating the roles of microRNAs associated with nonalcoholic fatty liver disease in hepatocellular carcinoma tumorigenesis: a systematic review and network analysis.
Journal: Frontiers in medicine
Published: July 11, 2024
Angiotensin II depends on hippo/YAP signaling to reprogram angiogenesis and promote liver fibrosis.
Journal: Cellular signalling
Published: May 22, 2024
Prediction of the mechanisms of action of Qutan Huoxue decoction in non-alcoholic steatohepatitis (NASH): a network pharmacology study and experimental validation.
Journal: Pharmaceutical biology
Published: March 13, 2023
Traditional Chinese medicine combined with radiofrequency ablation improves primary liver cancer outcomes: A systematic review with meta-analysis.
Journal: Heliyon
Published: December 30, 2022
Identification of a novel ANK1 mutation in a Chinese family with hereditary spherocytosis: A case report.
Journal: Experimental and therapeutic medicine
Published: August 04, 2022
Gamma knife radiosurgery versus transcatheter arterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score matching study.
Journal: Hepatology international
Published: December 22, 2021
Effects of Qutan Huoxue Formula on the SOCS1/TLR4 Signaling Pathway in NASH Model Mice.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: May 07, 2020
Effects of Qutanhuoxue Decoction on AQP7 and AQP9 Expression in Nonalcoholic Fatty Liver Model Rats.
Effects of Qutanhuoxue Decoction on AQP7 and AQP9 Expression in Nonalcoholic Fatty Liver Model Rats.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: November 09, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026